June 26, 2019
Webinar
A well-planned patent portfolio is essential in today’s pharmaceutical market as the technological, political, and financial landscapes continue to evolve and impart significant changes in the industry. At one time, the “blockbuster” drug model, where drug companies were targeting diseases affecting large patient populations to achieve high-volume sales, was the norm, but today, we see a focus on research and development dollars going into disease niches. Regardless of whether the product is a “blockbuster” or niche buster, we examine considerations and strategies to protect those innovations, from advanced development to commercial release.
Topics to be discussed include:
This webinar is the second segment of Finnegan’s 2019 series, “Practical Advice on U.S. Patent Law Issues.” We hope you are able to attend.
Speakers:
Paul W. Browning, Ph.D.
Adriana L. Burgy
Moderator:
Ming-Tao Yang
Date:
Wednesday, June 26, 2019
Time:
7:30 - 8:30 a.m. India
10:00 - 11:00 a.m. China/Taiwan
11:00 a.m. - 12:00 p.m. Japan/Korea
Scheduling Conflict? Finnegan records all hosted webinars. To view the recorded program, simply register for the webinar and you will receive an access link shortly after the live program is complete.
Workshop
Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law
May 2, 2024
Cambridge
Conference
2nd Annual Forum on IP, Funding and Tech Strategies for Novel Therapeutic Modalities
March 20, 2024
Boston
INCONTESTABLE® Blog
Trademark Application for Fruity Pebbles’ Colors—“Yabba-Dabba-Delicious” but Not Protectable
March 8, 2024
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.